Major Vasculitis Drug Study Retracted from New England Journal of Medicine

AI Insight

This is a retraction notice for a previously published article by Jayne et al. that appeared in the New England Journal of Medicine in 2021, which reported on avacopan as a treatment for ANCA-associated vasculitis. The original study has been withdrawn from the scientific record, meaning the findings should no longer be cited or relied upon for clinical decision-making.

Why it matters

ANCA-associated vasculitis is a serious autoimmune condition, and treatment decisions must be based on reliable evidence. This retraction affects the evidence base for avacopan therapy and requires clinicians and researchers to reassess treatment guidelines that may have incorporated the original study's conclusions.